发明名称 |
Process for the treatment of humans suffering from undesired urotoxic side effects caused by cytostatically active alkylating agents |
摘要 |
The invention is related to a process for the treatment of humans suffering from undesired urotoxic side effects caused by cytostatically active alkylating agents administered to them against malign tumors, comprising administering a pharmacologically acceptable salt of a mercapto alkane sulfonic acid having the general formula HS-alk-SO34 to the human treated with the cytostatically active alkylating agent, in an amount ranging from 20% of the weight of the alkylating agent to the highest tolerated dosage of the salt of the mercapto alkane sulfonic acid, simultaneously or separately in combination with the alkylating agent.
|
申请公布号 |
US4220660(A) |
申请公布日期 |
1980.09.02 |
申请号 |
US19780967000 |
申请日期 |
1978.12.06 |
申请人 |
ASTA-WERKE AG CHEMISCHE FABRIK |
发明人 |
BROCK, NORBERT |
分类号 |
A61K31/185;A61K31/675;A61P35/00;A61P39/02;(IPC1-7):A61K31/18 |
主分类号 |
A61K31/185 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|